NeoGenomics Inc. (NASDAQ: NEO) established initial surge of 12.06% at $8.27, as the Stock market unbolted on May 12, 2022. During the day, the stock rose to $8.31 and sunk to $7.26 before settling in for the price of $7.38 at the close. Taking a more long-term approach, NEO posted a 52-week range of $7.30-$54.74.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
It was noted that the giant of the Healthcare sector posted annual sales growth of 15.90% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 29.40%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -286.40%. This publicly-traded company’s shares outstanding now amounts to $122.59 million, simultaneously with a float of $121.06 million. The organization now has a market capitalization sitting at $1.07 billion. At the time of writing, stock’s 50-day Moving Average stood at $13.39, while the 200-day Moving Average is $31.24.
It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 2000 workers. For the Profitability, stocks gross margin was +37.08, operating margin was -19.66 and Pretax Margin of -3.11.
NeoGenomics Inc. (NEO) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the NeoGenomics Inc. industry. NeoGenomics Inc.’s current insider ownership accounts for 1.10%, in contrast to 96.70% institutional ownership. According to the most recent insider trade that took place on Mar 07, this organization’s Chief Financial Officer sold 3,209 shares at the rate of 18.29, making the entire transaction reach 58,693 in total value, affecting insider ownership by 98,516. Preceding that transaction, on Dec 21, Company’s Chief Financial Officer sold 1,846 for 35.00, making the whole transaction’s value amount to 64,610. This particular insider is now the holder of 11,689 in total.
NeoGenomics Inc. (NEO) Earnings and Revenue Records
Going through the last 3-months fiscal report unveiled on the 3/30/2022, it has been observed that the corporation posted -$0.2 earnings per share (EPS) during the time that was better the consensus figure (set at -$0.23) by $0.03. This company achieved a net margin of -1.72 while generating a return on equity of -0.93. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
NeoGenomics Inc.’s EPS decrease for this current 12-month fiscal period is -286.40% and is forecasted to reach -0.54 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 1.30% through the next 5 years, which can be compared against the 29.40% growth it accomplished over the previous five years trading on the market.
NeoGenomics Inc. (NASDAQ: NEO) Trading Performance Indicators
Let’s observe the current performance indicators for NeoGenomics Inc. (NEO). It’s Quick Ratio in the last reported quarter now stands at 7.50. The Stock has managed to achieve an average true range (ATR) of 0.88. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.20.
In the same vein, NEO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.33, a figure that is expected to reach -0.22 in the next quarter, and analysts are predicting that it will be -0.54 at the market close of one year from today.
Technical Analysis of NeoGenomics Inc. (NEO)
Now, what If we examine the latest scores posted by [NeoGenomics Inc., NEO]. During the last 5-days, its volume was better the volume of 1.94 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 15.10% While, its Average True Range was 0.90.
Raw Stochastic average of NeoGenomics Inc. (NEO) in the period of the previous 100 days is set at 3.59%, which indicates a major fall in contrast to 23.49% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 91.12% that was lower than 98.48% volatility it exhibited in the past 100-days period.